Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Seagen Inc (SGEN)  
$228.74 0.00 (0.00%) as of 4:30 Wed 12/13


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 180,310,000
Market Cap: 41.24(B)
Last Volume: 799,597 Avg Vol: 864,930
52 Week Range: $191.51 - $228.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 39,326 484,602
Total Sell Value $0 $0 $8,245,949 $88,100,996
Total People Sold 0 0 7 8
Total Sell Transactions 0 0 18 70
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 1805
  Page 48 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dobmeier Eric Chief Operating Officer   •       –      –    2012-04-25 4 OE $10.20 $255,957 D/D 25,000 78,708     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2012-04-20 4 AS $19.51 $746,862 D/D (38,281) 17,643     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2012-04-20 4 OE $5.63 $215,522 D/D 38,281 55,924     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2012-04-17 4 AS $18.88 $834,855 D/D (44,219) 17,643     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2012-04-17 4 OE $5.63 $257,653 D/D 44,219 46,080     -
   Siegall Clay B President & CEO   •       •      –    2012-03-19 4 GD $0.00 $0 D/D 5,000 1,096,711     -
   Lippman Marc E Director   –       •      –    2012-03-19 4 OE $4.97 $37,275 D/D 7,500 117,950     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-03-19 4 AS $19.75 $744,575 D/D (37,700) 31,073     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-03-19 4 OE $8.24 $310,648 D/D 37,700 68,773     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-03-16 4 AS $19.75 $45,425 D/D (2,300) 31,073     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-03-16 4 OE $8.24 $18,952 D/D 2,300 33,373     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2012-03-13 4 S $18.59 $1,294,173 D/D (69,626) 17,643     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2012-03-13 4 OE $3.30 $468,168 D/D 69,626 54,204     -
   Boerner Christopher S. SVP, Commercial   •       –      –    2012-02-29 4 A $0.00 $0 D/D 14,000 21,348     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2012-02-28 4 S $18.52 $851,938 D/D (46,000) 72,073     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2012-02-28 4 OE $10.20 $471,570 D/D 46,000 99,844     -
   Boerner Christopher S. SVP, CommercialOfficer   •       –      –    2012-02-22 3 IO $0.00 $0 D/D 0 7,348     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-01-27 4 AS $19.75 $790,000 D/D (40,000) 30,169     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-01-27 4 OE $8.24 $329,600 D/D 40,000 70,169     -
   Siegall Clay B President and CEO   •       •      –    2012-01-03 4 AS $16.73 $250,959 D/D (15,000) 1,045,055     -
   Siegall Clay B President and CEO   •       •      –    2012-01-03 4 OE $6.34 $95,100 D/D 15,000 1,060,055     -
   Baker Felix Director   –       •       •   2011-12-30 4 OE $6.25 $425,038 I/I 68,006 539,130     -
   Baker Felix Director   –       •       •   2011-12-30 4 OE $6.25 $2,219,644 I/I 355,143 15,131,223     -
   Baker Felix Director   –       •       •   2011-12-30 4 OE $6.25 $309,769 I/I 49,563 450,461     -
   Baker Felix Director   –       •       •   2011-12-30 4 OE $6.25 $2,123,675 I/I 339,788 4,966,001     -
  1805 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 48 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us